Tax & Penalty6 Aug 2026, 07:51 pm
GSK Pharma Receives ₹52 Cr IT Refund
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd has received a final order from the ACIT Cir 7(1)(1) confirming a refund of ₹52 crores. This refund is post an order from the CIT-Appeal for the assessment year 1984-85. The company will credit an interest income of ₹42.09 crores on this refund to its Profit & Loss account. The demand liability associated with this order was ₹23.21 crores.
Key Highlights
- Received IT refund of ₹52 crores.
- Interest income of ₹42.09 crores to be credited to P/L.
- Refund relates to assessment year 1984-85.
- Demand liability was ₹23.21 crores.
Price Impact
More from GLAXO